Pituitary Tumor Causes
Pituitary Tumor Causes
A pituitary tumour arises from the hormone-producing cells of the pituitary gland itself, which is why a tumour that keeps making its cell of origin's hormone raises that hormone. In most patients no cause can be identified: no diet, habit or environmental exposure has been shown to cause these tumours. In a minority the tumour is part of an inherited syndrome — multiple endocrine neoplasia type 1, familial isolated pituitary adenoma, or a change in the AIP gene — and those are suspected on age, family history or other tumours rather than assumed.
Where the tumour comes from
The origin of the tumour explains both what it is and why it behaves in two directions at once:
- It arises from the gland's own cells — the cells of the front part of the pituitary that manufacture and release hormones. That is why the classification of these tumours follows the cell they came from, and why a tumour that continues to make its cell's hormone raises that hormone in the blood.
- It grows inside a small bony hollow. The pituitary sits in a hollow at the base of the skull with the optic chiasm directly above, the cavernous sinus on either side, and the sphenoid sinus below. There is no room to spare, which is why even a small tumour can press on something that matters.
- It is benign in the ordinary case — it does not spread, and it does not invade the brain. The clinical questions are about hormones and about pressure, which is why the vocabulary of cancer — spread, margins, stages — does not apply here.
- It arises where the cells are, not where a cause was. There is no local factor to point to, and no history that predicts who will develop one.
What the hormone tells you about the tumour
The hormone a tumour produces is not incidental — it determines the disease it causes, and to some extent how the tumour behaves:
- Prolactin-producing tumours raise prolactin, which suppresses the normal reproductive cycle. They are the commonest functioning tumours, and the one type for which medication is the first-line treatment.
- Growth hormone-producing tumours cause acromegaly. They are usually treated with surgery first, with medication used to control the hormone where surgery is not sufficient.
- ACTH-producing tumours drive the adrenal glands to make too much cortisol, causing Cushing's disease. Surgery is the usual first step, with medication used where surgery is not possible or not enough.
- A raised prolactin does not always mean the tumour makes it. A tumour that compresses the stalk interrupts the signal that normally restrains prolactin, so the level rises without the tumour producing the hormone. The distinction matters because it changes the treatment, and it is one of the reasons a mild rise is interpreted with care.
The inherited syndromes
These account for a minority of pituitary tumours, and they deserve a precise account because recognising them changes the follow-up for life:
- Multiple endocrine neoplasia type 1 — an inherited syndrome in which pituitary tumours may occur alongside tumours of the parathyroid and pancreatic glands. In this setting the pituitary tumour is sometimes the first manifestation, which is why a young patient with a pituitary tumour may be asked about other symptoms and about the family.
- Familial isolated pituitary adenoma — pituitary tumours in more than one family member, without the other features of a named syndrome. It is recognised as its own entity, and its identification changes what relatives are offered.
- AIP gene changes — associated with pituitary tumours presenting at a younger age and often with a family history; they make assessment and defined follow-up appropriate.
- What a diagnosis changes — scheduled imaging and blood tests for the pituitary and for the other glands involved, for a lifetime; a lower threshold for investigating new symptoms; and information that matters to relatives, which a genetics service is the right place to arrange.
Age, sex and the way the tumour is found
Who these tumours are found in, and why the pattern differs between men and women:
- Middle adult life — most pituitary tumours are diagnosed in adults in midlife, though they occur across a wide age range and inherited forms present considerably younger.
- Prolactin-producing tumours are found differently in women and men — because a raised prolactin interrupts the menstrual cycle in women, it comes to attention early and often; in men the equivalent symptoms are quieter, so these tumours tend to be larger by the time they are found. This is a difference in when the tumour is noticed rather than in the disease itself.
- Hormone-producing and non-functioning tumours differ in how they appear at all — a functioning tumour announces itself through its hormone; a non-functioning tumour has no such signal and waits until it presses on something.
- None of this is a risk factor a person can act on. Age and sex describe when and in whom the tumour is found; they do not describe anything that could have been done differently.
Explanations that are not supported
Several widely repeated explanations can be set aside, and doing so is useful because it redirects attention to what can be acted on:
- Stress and lifestyle. No diet, occupational exposure or environmental agent has been established as a cause of pituitary tumours, despite study.
- Head injury. A blow to the head does not cause a pituitary tumour. It sometimes leads to a scan that finds one, and it can occasionally damage the gland itself — which is a different matter, and a common source of the misunderstanding.
- Medication taken in the past. Patients often look back for something they took years earlier. No such link has been established, and the search usually delays attention to a finding that needs it now.
- The hormone symptoms were caused by the tumour, not the other way round. Weight change, loss of periods or high blood pressure are consequences of the tumour producing a hormone, not the cause of it — which is worth stating because some patients assume their symptoms generated the tumour.
- Supplements and herbal remedies. None has been shown to shrink a pituitary tumour, and some interact with the medication used to control the hormone, which makes taking them without discussion a real risk rather than a neutral choice.
Who is actually at risk
Putting the factors in one place, in order of how firmly they are established:
- People with an inherited syndrome — multiple endocrine neoplasia type 1, familial isolated pituitary adenoma, or an AIP gene change. These are the groups with a defined surveillance programme, and they are a minority of all patients.
- Adults in midlife — the period in which most sporadic tumours are diagnosed, though the reason is largely that this is when they are looked for.
- People with a family history of pituitary tumours — a first-degree relative with a pituitary tumour is a reason for assessment rather than surveillance in everyone.
- Everyone else — no lifestyle, occupational or environmental factor has been shown to change the risk, and nothing a person did or failed to do brought the tumour about.